These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3190702)

  • 21. Glycogenolytic effect of pancreastatin in the rat.
    Sanchez V; Calvo JR; Goberna R
    Biosci Rep; 1990 Feb; 10(1):87-91. PubMed ID: 2187544
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Secretion of pancreastatins from the porcine digestive tract.
    Jensen TD; Holst JJ; Fahrenkrug J
    Scand J Gastroenterol; 1994 Apr; 29(4):376-84. PubMed ID: 8047816
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of glucose-stimulated insulin release in the perfused rat pancreas by parathyroid secretory protein-I (chromogranin-A).
    Greeley GH; Thompson JC; Ishizuka J; Cooper CW; Levine MA; Gorr SU; Cohn DV
    Endocrinology; 1989 Mar; 124(3):1235-8. PubMed ID: 2645112
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of pancreastatin on pancreatic hormone secretion in the dog.
    Ribes G; Vecina F; Hillaire-Buys D; Ahren B
    Horm Res; 1990; 33(5):194-8. PubMed ID: 1980260
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of porcine pancreastatin on endocrine function of canine pancreas.
    Ohneda A; Koizumi F; Ohneda M
    Tohoku J Exp Med; 1989 Dec; 159(4):291-8. PubMed ID: 2699104
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of CCK antagonist L-364,718, pancreastatin (33-49) and a somatostatin analogue on camostate-induced rat pancreatic hypertrophy.
    Schmidt WE; Stöckmann F; Choudhury AR; Wilms HM; Siegel EG; Nustede R; Fölsch UR; Creutzfeldt W
    Digestion; 1989; 44(2):105-16. PubMed ID: 2612749
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pancreastatin inhibits pancreatic enzyme secretion by presynaptic modulation of acetylcholine release.
    Herzig KH; Louie DS; Tatemoto K; Chung OY
    Am J Physiol; 1992 Jan; 262(1 Pt 1):G113-7. PubMed ID: 1370747
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development and regulation of porcine pancreatic function.
    Pierzynowski SG; Weström BR; Svendsen J; Svendsen L; Karlsson BW
    Int J Pancreatol; 1995 Oct; 18(2):81-94. PubMed ID: 8530834
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of synthetic human cholecystokinin-33 on exocrine pancreas.
    Doi R; Inoue K; Kogire M; Sumi S; Yun M; Futaki S; Fujii N; Yajima H; Tobe T
    Biochem Biophys Res Commun; 1988 Feb; 150(3):1251-5. PubMed ID: 3342068
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pancreastatin and its 33-49 C-terminal fragment inhibit glucagon-stimulated insulin in vivo.
    Sánchez-Margalet V; Calvo JR; Lucas M; Goberna R
    Gen Pharmacol; 1992 Jul; 23(4):637-8. PubMed ID: 1397969
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pancreastatin, a presumed product of chromogranin-A (secretory protein-I) processing, inhibits secretion from porcine parathyroid cells in culture.
    Fasciotto BH; Gorr SU; DeFranco DJ; Levine MA; Cohn DV
    Endocrinology; 1989 Sep; 125(3):1617-22. PubMed ID: 2759035
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pancreastatin--a novel regulatory peptide?
    Schmidt WE; Creutzfeldt W
    Acta Oncol; 1991; 30(4):441-9. PubMed ID: 1854501
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Secretion of pancreastatins from isolated, perfused, porcine adrenal glands.
    Jensen TD; Fahrenkrug J; Holst JJ
    Peptides; 1994; 15(3):519-27. PubMed ID: 7937328
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glucose-dependent insulinotropic action of cholecystokinin and caerulein in the isolated perfused rat pancreas.
    Sakamoto C; Otsuki M; Ohki A; Yuu H; Maeda M; Yamasaki T; Baba S
    Endocrinology; 1982 Feb; 110(2):398-402. PubMed ID: 6173205
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pancreastatin molecular forms in normal human plasma.
    Kitayama N; Tateishi K; Funakoshi A; Miyasaka K; Shimazoe T; Kono A; Iwamoto N; Matsuoka Y
    Life Sci; 1994; 54(21):1571-8. PubMed ID: 8196476
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intracranial microinfusion of pancreastatin elevates blood glucose, free fatty acids, and corticosterone in rats.
    Gunion MW; Rosenthal MJ; Tatemoto K; Morley JE
    Brain Res; 1989 Apr; 485(2):251-7. PubMed ID: 2720411
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pancreastatin: further evidence for its consideration as a regulatory peptide.
    Sánchez-Margalet V; Lucas M; Goberna R
    J Mol Endocrinol; 1996 Feb; 16(1):1-8. PubMed ID: 8672228
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma pancreastatin responses after intrajejunal infusion of liquid meal in patients with chronic pancreatitis.
    Funakoshi A; Tateishi K; Shinozaki H; Miyasaka K; Ito T; Wakasugi H
    Dig Dis Sci; 1990 Jun; 35(6):721-5. PubMed ID: 2188821
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current status on chromogranin A and pancreastatin.
    Robberecht P; Lingier P; Woussen-Colle MC
    Acta Gastroenterol Belg; 1993; 56(3-4):261-3. PubMed ID: 8266767
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exocrine pancreatic secretion in response to a new CCK-analog, CCK33 and caerulein in dogs.
    Beglinger C; Solomon TE; Gyr K; Moroder L; Wünsch E
    Regul Pept; 1984 Jul; 8(4):291-6. PubMed ID: 6548569
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.